It was the chance to try to help people, even at their sickest, that drew Dr. Steven Crowley to medicine 25 years ago. Today the nephrologist still sees patients at the Durham VA Medical Center, but he spends much more time decoding how immune system cells contribute to hypertension and organ damage in his laboratory. Still, the mission endures. “The most important aspect of our work is to show solidarity with our patients. That is something we can always do, regardless of the stage of their illness,” says Crowley, whose research may lay groundwork for needed improved treatments.
Lisa Criscione-Schreiber, MD, MEd , associate professor of medicine (Rheumatology and Immunology), has been selected to serve as the next chair of the Program for Women in Internal Medicine , announced Laura Svetkey, MD, MHS, vice chair for faculty development and diversity in the Department of Medicine.
Dorothy Sipkins, MD, PhD , is a hematologist-oncologist who studies cancer. But to understand the cleverness of her work, it’s helpful to think of her as an ecologist—a cell ecologist. Sipkins identifies very specific biological habitats and interactions that allow malignant cells to move, proliferate and survive chemical attacks, traits that too often produce fatal disease. “I love thinking about what is on the outside of the cell. What the cell is seeing. What the cell is interacting with, the 3-D environment it interacts with,” says Sipkins.
Marie A. Bernard, MD , deputy director of the National Institute on Aging, will give the 2018 Phillips-Winn Memorial Grand Rounds on Fri., Dec. 1 . Her presentation title is "From Mice to Men: Highlights of National Institute on Aging." Continue reading for more on Dr. Bernard.
Duke Health has announced a new class of the Duke Clinical Leadership Program (DCLP), including eight faculty from the Department of Medicine. The 26 clinicians in the 2018 class will join the ranks of the 169 fellows who completed the DCLP program during its first seven years.
David Casarett, MD , section chief of Palliative Care, and Arif Kamal, MD, MHS, MBA , associate professor of medicine (Medical Oncology), are among 30 individuals who have been recognized by the American Academcy of Hospice and Palliative Medicine as "Visionaries in Hospice and Palliative Medicine."